OR WAIT null SECS
February 06, 2020
Contract partners must help innovators, especially smaller and virtual companies, consider manufacturability as early as possible in development. This requires focusing on technical and operational performance, as well as cost.
February 02, 2020
Vein-to-vein programs are focusing on data access and traceability.
February 01, 2020
As cell and gene therapies become more prominent, industry is seeking the expertise and capabilities of outsourcing partners to ensure success.
The need for manufacturing speed inspires contract manufacturers to explore advanced processing technologies.
January 29, 2020
The new facility, to be operated under the newly formed CDMO, The Center for Breakthrough Medicines, will be located in King of Prussia, PA, and will increase manufacturing capacity for cell and gene therapies.
January 23, 2020
The new course is directed at analyzing the skills gap in the manufacture of cell and gene therapies as they progress toward manufacturing at scale.
January 22, 2020
The new company will work to provide the manufacturing technologies and processes needed to develop and commercialize new cell and gene therapies through individual company products and expertise.
January 21, 2020
GE Healthcare Life Sciences’ new facility for cell and gene processing supplies will be open in 2022.
January 13, 2020
The therapy is currently approved in the EU as a gene therapy for the treatment of patients 12 years and older with transfusion-dependent β-thalassemia.
December 17, 2019
The deal was approved by the Federal Trade Commission following a 10-month investigation.